← All stories
Markets
Kanabo Group (LSE:KNB) strategy brings cash conversion into view
Highlights Kanabo Group should be judged on whether medical cannabis products and digital healthcare services can support repeatable demand and stronger financial outcomes. The central risk test covers cash resources, patient adoption and r…
Covered by 1 outlet
All coverage · 1 article